Works matching IS 13866346 AND DT 2025 AND VI 55 AND IP 6

Results: 16
    1
    2

    Nationwide survey of patients with acute liver failure and late‐onset hepatic failure in Japan seen between 2016 and 2021.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 932, doi. 10.1111/hepr.14191
    By:
    • Nakayama, Nobuaki;
    • Nakao, Masamitsu;
    • Uchida, Yoshihito;
    • Ido, Akio;
    • Takikawa, Yasuhiro;
    • Kakisaka, Keisuke;
    • Kato, Naoya;
    • Chayama, Kazuaki;
    • Inoue, Kazuaki;
    • Kasahara, Mureo;
    • Terai, Shuji;
    • Ohira, Hiromasa;
    • Sakaida, Isao;
    • Takami, Taro;
    • Hasegawa, Kiyoshi;
    • Abe, Masanori;
    • Shimizu, Masahito;
    • Yoshiji, Hitoshi;
    • Genda, Takuya;
    • Inui, Ayano
    Publication type:
    Article
    3
    4

    Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 883, doi. 10.1111/hepr.14189
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Hayashi, Katsumi;
    • Kondo, Hiromu;
    • Anbe, Kaiki;
    • Mizoshita, Tsutomu;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Inada, Hiroki;
    • Tokunaga, Takayuki;
    • Narahara, Satoshi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    5

    Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 948, doi. 10.1111/hepr.14188
    By:
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Shindoh, Junichi;
    • Matsumura, Masaru;
    • Okubo, Satoshi;
    • Tominaga, Licht;
    • Yamamoto, Shigeki;
    • Eriksson, Yasuka;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kozuka, Takuyo;
    • Kumada, Hiromitsu
    Publication type:
    Article
    6
    7

    Prognostic significance of skeletal muscle mass in patients with alcohol‐related cirrhosis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 868, doi. 10.1111/hepr.14186
    By:
    • Shibamoto, Akihiko;
    • Namisaki, Tadashi;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Kubo, Takahiro;
    • Koizumi, Aritoshi;
    • Tanaka, Misako;
    • Matsuda, Takuya;
    • Inoue, Takashi;
    • Tsuji, Yuki;
    • Fujinaga, Yukihisa;
    • Nishimura, Norihisa;
    • Sato, Shinya;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Mitoro, Akira;
    • Asada, Kiyoshi;
    • Takaya, Hiroaki;
    • Akahane, Takemi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Issue Information.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 783, doi. 10.1111/hepr.14068
    Publication type:
    Article